Agenus (AGEN) Net Cash Flow Growth (3y) (2013 - 2026)
Agenus (AGEN) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,019.86 Bn | 66,019.58 Bn | - | -50.33% |
| 2 | Nanobiotix | 1,909.20 Bn | 1,909.14 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 468.20 Bn | 463.41 Bn | 1.35 Bn | 38.47% |
| 5 | Vertex Pharmaceuticals | 122.50 Bn | 115.26 Bn | 2.59 Bn | 33.37% |
| 6 | Regeneron Pharmaceuticals | 70.15 Bn | 61.39 Bn | 3.31 Bn | -29.82% |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - | - |
| 8 | Argenx Se | 55.58 Bn | 50.39 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.43 Bn | 959.66 Mn | 32.17% |
| 10 | Agenus | 228.40 Mn | 193.41 Mn | 33.74 Mn | 62.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62.93% |
| Dec 31, 2025 | 75.07% |
| Sep 30, 2025 | 25.89% |
| Jun 30, 2025 | 23.00% |
| Mar 31, 2025 | 20.60% |
| Dec 31, 2024 | -28.50% |
| Sep 30, 2024 | -31.35% |
| Jun 30, 2024 | 42.33% |
| Mar 31, 2024 | -46.67% |
| Dec 31, 2023 | -36.97% |
| Sep 30, 2023 | -44.62% |
| Jun 30, 2023 | -17.36% |
| Mar 31, 2023 | -34.84% |
| Dec 31, 2022 | 1.74% |
| Sep 30, 2022 | 11.82% |
| Jun 30, 2022 | 18.96% |
| Mar 31, 2022 | -34.21% |
| Dec 31, 2021 | 71.39% |
| Sep 30, 2021 | 290.35% |
| Jun 30, 2021 | -74.88% |